The efficacy of a slow-release albendazole capsule against <i>Haemonchus contortus</i> with known resistance to albendazole

Controlled-release albendazole capsules (CRCs) are currently registered for use in Australia and New Zealand as anthelmintic treatment in sheep. However, reports on the efficacy of such products on resistant parasite populations are sometimes controversial. This is the first study to report on the e...

Full description

Bibliographic Details
Main Authors: Alan D. Fisher, Sybrand J. van Sittert
Format: Article
Language:English
Published: AOSIS 2013-12-01
Series:Journal of the South African Veterinary Association
Subjects:
Online Access:https://jsava.co.za/index.php/jsava/article/view/1000
Description
Summary:Controlled-release albendazole capsules (CRCs) are currently registered for use in Australia and New Zealand as anthelmintic treatment in sheep. However, reports on the efficacy of such products on resistant parasite populations are sometimes controversial. This is the first study to report on the efficacy of such products under South African field conditions in sheep harbouring a population of Haemonchus contortus with known multiple anthelmintic resistance, including to albendazole. Treatment groups were comprised of CRC-treated and single dose albendazole-treated sheep, as well as negative controls. Groups were compared by using faecal egg count reduction tests, FAMACHA© anaemia scoring, conception rates and comparative weight gains over three and a half months. Based on a comparison of faecal egg counts, no advantage could be found using CRCs. Moreover, the use of the product actually decreased weight gain when compared with the control group animals.
ISSN:1019-9128
2224-9435